Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] Preprints.org Not all peptides are restricted. Here's the breakdown you actually need. The FDA's Category 2 classification affects specific compounded peptides BPC 157, TB 500, CJC 1295 Ipamorelin, AOD 9604, Epithalon, Selank, Semax. Others like Sermorelin Recognizing and Monitoring for Adverse Events ENCOMPASS Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] Preprints.org Full article: Immune Related Adverse Events with PD 1 Versus PD L1 Inhibitors: A Meta Analysis of 8730 Patients from Clinical Trials